Kidney disease-related drug developed by Ardelyx approved by the US FDA.

IKCS: International Kidney Cancer Symposium

Large GLP-1 Drug Review Takes Closer Look at Risks, Rewards

Some potential non-cardiometabolic benefits lack strong evidence

Low-Income Patients Benefit From Intensive Blood Pressure Management

Trial included federally qualified health centers running SPRINT-like protocol

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

But similar bills haven't succeeded

FDA Approves Sparsentan as First FSGS Treatment

Expanded indication supported by mixed bag of trial data

Low Hemoglobin Levels Linked to Higher Dementia Risk

Risk peaked when anemia occurred alongside abnormal Alzheimer's biomarkers

Primary Care Intervention Fails to Cut Heart Disease Risks

Multipronged education and feedback intervention for clinics did not have intended results

Rural Dialysis Unit Closes Despite State Getting $219M in Rural Health Funding

The influx of money is out of reach

Differentiating the Trio of Focal Segmental Glomerulosclerosis Causes

Primary, secondary, and genetic cases require different treatment plans

Moderate Diet Change Tied to Renal Benefit in CKD

Findings suggest protein restriction doesn't have to be extreme

Kids' Acute Kidney Injury Linked to These Lasting Health Risks

Meta-analysis details "long-term health issues that require ongoing monitoring"

Risk of Focal Segmental Glomerulosclerosis Recurrence After Kidney Transplant

Recurrence after kidney transplant linked to graft loss and mortality

He Took His Vitamins, Then Developed a Rare Kidney Stone

Case report links inactive ingredients, Ramadan fasting to unusual stone composition

Persistent Shoulder Pain in a Dialysis Patient?

Consider metastatic or ectopic calcification in diagnosing unexplained symptoms in ESRD patients

Case Report: Dialysis Patient Develops Challenging Comorbidity

Elderly man with end-stage renal disease presents with evolving and unexplained symptoms

Protein Supplement Tied to Better Outcomes for Patients on Dialysis

Post-hemodialysis liquid protein associated with fewer and shorter hospitalizations